BioNexus Gene Lab Corp. Cost of Revenue
BioNexus Gene Lab Corp. (BGLC) reported Cost of Revenue of $63.17 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2026-08-14
- BioNexus Gene Lab Corp. cost of revenue for the quarter ending 2026-06-30 was $63.17K, a 96.66% decline year-over-year.
- BioNexus Gene Lab Corp. cost of revenue for the quarter ending 2026-03-31 was $23.63K, a 98.68% decline year-over-year.
- BioNexus Gene Lab Corp. cost of revenue for the quarter ending 2025-12-31 was $487.74K, a 77.98% decline year-over-year.
- BioNexus Gene Lab Corp. cost of revenue for the quarter ending 2025-09-30 was $2.17M, a 5.98% decline year-over-year.
- BioNexus Gene Lab Corp. cost of revenue for fiscal 2025 was $6.34M, a 22.89% decline from fiscal 2024.
- BioNexus Gene Lab Corp. cost of revenue for fiscal 2024 was $8.22M, a 2.61% decline from fiscal 2023.
- BioNexus Gene Lab Corp. cost of revenue for fiscal 2023 was $8.44M, a 12.70% decline from fiscal 2022.
- BioNexus Gene Lab Corp. cost of revenue for fiscal 2022 was $9.67M, a 12.85% decline from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $63.17K 10-Q · filed 2026-08-14 | $86.81K 10-Q · filed 2026-08-14 | $574.55K derived: sum of 3 quarters · filed 2026-08-14 | $2.74M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $23.63K 10-Q · filed 2026-05-15 | $511.38K derived: sum of 2 quarters · filed 2026-05-15 | $2.68M derived: sum of 3 quarters · filed 2026-05-15 | $4.57M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $487.74K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $2.65M derived: sum of 2 quarters · filed 2026-04-14 | $4.55M derived: sum of 3 quarters · filed 2026-08-14 | $6.34M 10-K · filed 2026-04-14 | ||||
| 2025-09-30 | $2.17M 10-Q · filed 2025-11-14 | $4.06M derived: sum of 2 quarters · filed 2026-08-14 | $5.85M 10-Q · filed 2025-11-14 | $8.07M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $1.89M 10-Q · filed 2026-08-14 | $3.69M 10-Q · filed 2026-08-14 | $5.90M derived: sum of 3 quarters · filed 2026-08-14 | $8.20M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $1.79M 10-Q · filed 2026-05-15 | $4.01M derived: sum of 2 quarters · filed 2026-05-15 | $6.31M derived: sum of 3 quarters · filed 2026-05-15 | $8.00M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $4.52M derived: sum of 2 quarters · filed 2026-04-14 | $6.20M derived: sum of 3 quarters · filed 2026-04-14 | $8.22M 10-K · filed 2026-04-14 | ||||
| 2024-09-30 | $2.30M 10-Q · filed 2025-11-14 | $3.99M derived: sum of 2 quarters · filed 2025-11-14 | $6.01M 10-Q · filed 2025-11-14 | $8.01M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $1.69M 10-Q · filed 2025-08-18 | $3.70M 10-Q · filed 2025-08-18 | $5.71M derived: sum of 3 quarters · filed 2025-08-18 | $7.91M derived: sum of 4 quarters · filed 2025-08-18 | ||||
| 2024-03-31 | $2.02M 10-Q · filed 2025-05-15 | $4.02M derived: sum of 2 quarters · filed 2025-05-15 | $6.22M derived: sum of 3 quarters · filed 2025-05-15 | $8.45M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $4.21M derived: sum of 2 quarters · filed 2025-04-15 | $6.43M derived: sum of 3 quarters · filed 2025-04-15 | $8.44M 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | $2.20M 10-Q · filed 2024-11-15 | $4.43M derived: sum of 2 quarters · filed 2024-11-15 | $6.43M 10-Q · filed 2024-11-15 | $8.94M derived: sum of 4 quarters · filed 2024-11-15 | ||||
| 2023-06-30 | $2.23M 10-Q · filed 2024-08-14 | $4.24M 10-Q · filed 2024-08-14 | $6.74M derived: sum of 3 quarters · filed 2024-08-14 | $9.01M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $2.01M 10-Q · filed 2024-05-15 | $4.51M derived: sum of 2 quarters · filed 2024-05-15 | $6.78M derived: sum of 3 quarters · filed 2024-05-15 | $9.01M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $2.50M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | $4.78M derived: sum of 2 quarters · filed 2024-04-16 | $7.00M derived: sum of 3 quarters · filed 2024-04-16 | $9.67M 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | $2.28M 10-Q/A · filed 2024-03-26 | $4.50M derived: sum of 2 quarters · filed 2024-03-26 | $7.17M 10-Q/A · filed 2024-03-26 | $9.94M derived: sum of 4 quarters · filed 2024-03-26 | ||||
| 2022-06-30 | $2.22M 10-Q · filed 2023-08-16 | $2.24M 10-Q · filed 2022-08-15 | $4.89M 10-Q · filed 2023-08-16 | $4.94M 10-Q · filed 2022-08-15 | $7.66M derived: sum of 3 quarters · filed 2023-08-16 | $10.53M derived: sum of 4 quarters · filed 2023-08-16 | ||
| 2022-03-31 | $2.67M 10-Q · filed 2023-05-09 | $2.70M 10-Q · filed 2022-05-16 | $5.44M derived: sum of 2 quarters · filed 2023-05-09 | $8.31M derived: sum of 3 quarters · filed 2023-05-09 | $10.93M derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $5.63M derived: sum of 2 quarters · filed 2023-03-31 | $8.26M derived: sum of 3 quarters · filed 2023-03-31 | $11.10M 10-K · filed 2023-03-31 | $11.17M 10-K · filed 2022-04-06 | |||
| 2021-09-30 | $2.87M 10-Q · filed 2022-11-14 | $2.89M 10-Q · filed 2021-11-15 | $5.49M derived: sum of 2 quarters · filed 2022-11-14 | $8.33M 10-Q · filed 2022-11-14 | $8.38M 10-Q · filed 2021-11-15 | $12.10M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $2.62M 10-Q · filed 2022-08-15 | $5.49M 10-Q · filed 2022-08-15 | $9.23M derived: sum of 3 quarters · filed 2022-08-15 | $11.80M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $2.87M 10-Q · filed 2022-05-16 | $6.61M derived: sum of 2 quarters · filed 2022-05-16 | $9.18M derived: sum of 3 quarters · filed 2022-05-16 | $10.12M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $3.74M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $6.31M derived: sum of 2 quarters · filed 2022-04-06 | $7.26M derived: sum of 3 quarters · filed 2022-04-06 | $9.67M 10-K · filed 2022-04-06 | ||||
| 2020-09-30 | $2.57M 10-Q · filed 2021-11-15 | $15.25K 10-Q · filed 2020-11-03 | $3.51M derived: sum of 2 quarters · filed 2021-11-15 | $5.93M 10-Q · filed 2021-11-15 | $45.56K 10-Q · filed 2020-11-03 | $5.95M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $944.23K 10-Q · filed 2021-08-12 | $17.32K 10-Q · filed 2020-08-11 | $3.36M 10-Q · filed 2021-08-12 | $30.31K 10-Q · filed 2020-08-11 | $3.38M derived: sum of 3 quarters · filed 2021-08-12 | $3.39M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $2.41M 10-Q · filed 2021-05-18 | -$12.99K 10-Q · filed 2020-05-08 | $2.43M derived: sum of 2 quarters · filed 2021-05-18 | $2.45M derived: sum of 3 quarters · filed 2021-05-18 | $2.47M derived: sum of 4 quarters · filed 2021-05-18 | |||
| 2019-12-31 | $18.73K derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-03-30 | $35.23K derived: sum of 2 quarters · filed 2021-03-30 | $52.24K derived: sum of 3 quarters · filed 2021-03-30 | $71.07K 10-K · filed 2021-03-30 | -$71.07K 10-K · filed 2020-03-31 | |||
| 2019-09-30 | $16.50K 10-Q/A · filed 2020-11-09 | -$16.50K 10-Q · filed 2019-11-14 | $33.52K derived: sum of 2 quarters · filed 2020-11-09 | $52.34K 10-Q/A · filed 2020-11-09 | -$52.34K 10-Q · filed 2019-11-14 | -$1.44K derived: sum of 4 quarters · filed 2020-11-09 | ||
| 2019-06-30 | $17.02K 10-Q · filed 2020-08-11 | $35.84K 10-Q · filed 2020-08-11 | -$17.93K derived: sum of 3 quarters · filed 2020-08-11 | -$87.19K derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | -$18.82K 10-Q · filed 2020-05-08 | -$34.95K derived: sum of 2 quarters · filed 2020-05-08 | -$104.21K derived: sum of 3 quarters · filed 2020-05-08 | -$18.56K derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | -$16.13K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | -$85.39K derived: sum of 2 quarters · filed 2020-03-31 | $259.00 derived: sum of 3 quarters · filed 2020-03-31 | -$183.56K 10-K · filed 2020-03-31 | ||||
| 2018-09-30 | -$69.25K 10-Q · filed 2019-11-14 | $16.39K derived: sum of 2 quarters · filed 2019-11-14 | -$167.43K 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | $85.65K 10-Q · filed 2019-08-09 | $98.18K 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | -$12.53K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |